Biologics

Drug Shortages and You: Who's At Risk, What's the Fix?

John Horton | Posted 05.09.2012

Read More: Biosimilars, Methotrexate Shortage, Biologics, Legitscript, Fda-Drug-Shortage, Fda-Drug-Recalls, Drug Shortage, Fda Drug Shortage, Drug Shortages, Politics News
John Horton

Drug shortages are a complex problem with multiple causes, not least of all manufacturing issues that can affect the safety of injectable medicines like biologics.

Read Post

Medical Innovation and Shortening the Long Goodbye

John Horton | Posted 02.20.2012

Read More: Biologics, Early Alzheimer's, Alzheimer's Disease, Alzheimer's, Alzheimer's Symptoms, Dementia, Alzheimer's Dementia, Alzheimer's Care, Alzheimer, Alzheimer's Stages, Healthy Living News
John Horton

Today, too many families face President Reagan's "long goodbye" -- and too many Alzheimers' victims know, even as the disease begins to rob them of their memories, of the pain their families will face.

Read Post

Patient Safety Paramount for Cutting Edge Medicines

Gary Puckrein | Posted 02.05.2012

Read More: Affordable Care Act, Fda, Healthcare Reform, Medicine, Patient Safety, Healthcare, Biologics, Generic Drugs, Black Voices News
Gary Puckrein

It is crucial that the health care communities in both the public and private sector transform their data collection and testing approaches to account for the overall changing face of the American population.

Read Post

Data Exclusivity: Getting the Balance Right

John Horton | Posted 07.19.2011

Read More: Biosimilars, Biologics, Fda Regulations, Intellectual Property, Pharmaceuticals, Politics News
John Horton

What's the right length for data exclusivity? The current law says innovator drug makers have twelve years; in the European Union, it's ten; and the 2012 budget proposes seven. Who's right?

Read Post

Let's Not Return to the Days of Health Insurance Abuse

Sen. Sherrod Brown | Posted 05.25.2011

Read More: Donut Hole, Sherrod Brown, Biologics, Health, National Health Reform, Ohio, Health Reform, Congressional Budget Office, Politics News
Sen. Sherrod Brown

In America, a family should never be forced into bankruptcy because a child gets sick. In America, an Ohio family shouldn't be denied coverage if it r...

Read Post

Biologic Drugs May Be Cheaper, But Are They Safe?

John Horton | Posted 05.25.2011

Read More: Biologic New Medicine, What Are Biologics, Biologic Drugs, Biologics, Biologics Definition, Home News
John Horton

Biologics are an exciting new world of medicine. But the EMA's new guidelines should put patient safety first by requiring biosimilars to be held to the same safety and standards as the original drug.

Read Post

Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'

John Horton | Posted 05.25.2011

Read More: Biosimilars, FDA Biologics, FDA Biosimilars, FDA Biologic Drugs, Biosimilar Drugs, Biologic Drugs, Biologics, Home News
John Horton

As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.

Read Post

House Health Care Bill: A Death Sentence For My Fellow Breast Cancer Survivors

Jane Hamsher | Posted 05.25.2011

Read More: Health Care Bill, Anna Eshoo, Medical Students, Breast Cancer, Kay Hagan, Biologics, Nancy Pelosi, Avastin, Herceptin, Fda, Biologic Drugs, Health Care Reform, Politics News
Jane Hamsher

Pelosi made a choice about the lifesaving biologic drugs I took when I was in chemotherapy that will cost many fellow breast cancer survivors everything they own, and quite possibly their lives.

Read Post

Anna Eshoo's PhRMA Boondoggle: The Devil Is In Her Details

Jane Hamsher | Posted 05.25.2011

Read More: PhRMA Lobby, Anna Eshoo, Breast Cancer, Henry Waxman, Jay Inslee, Biologics, Boondoggle, Politics News
Jane Hamsher

Thank you, Rep. Eshoo, for your commitment to having a bill that does not allow for "evergreening." Now the question becomes -- how are we going to get one?

Read Post

Biologics: The Case for 13 or More Years of Data Exclusivity

Pat Choate | Posted 05.25.2011

Read More: Data Exclusivity, Therapies, Biologics, Medical, Research-and-Development, Drugs, Congress, Medicines, Drugs and Therapies, Technology News
Pat Choate

The United States will only realize this potential and remain the global leader in medical innovation if we maintain a strong environment for investment in the newest wave - biopharmaceuticals, also known as biologics.

Read Post

Protecting Pharmaceutical Profits: The Cost Is Human Lives

Jane Hamsher | Posted 05.25.2011

Read More: Anna Eshoo, Dr. Anthony So, Breast Cancer, Crohn's Disease, Herceptin, Kay Hagan, Biologics, Amsa, Politics News
Jane Hamsher

The public option has received the lion's share of attention in the health care debate, but there's an equally important issue relating to generic drugs that could mean lifesaving drugs remain too expensive for all but the wealthy.

Read Post

Before We Pass Health Insurance Reform, We Must Do More to Limit Big Pharma's Monopoly on Biologics

Marcy Winograd | Posted 05.25.2011

Read More: Pharmaceutical Industry, Hiv, Jane Harman, Breast Cancer, Biologics, Anna Eshoo, Health Insrance Reform, Big Pharma, Marcy Winograd, Aids, Jane Hamsher, Biolsimilars, Health Care, Politics News
Marcy Winograd

In Congress, I will work to support affordable prices on biologics, so that victims of cancer, HIV, diabetes, Parkinsons, rheumatoid arthritis, and multiple sclerosis can afford the medicine they need to stay alive.

Read Post

The Fight For Biogenerics

Hilary Kramer | Posted 05.25.2011

Read More: Anna Eshoo, Debra Barrett, Amgen, Biogenerics, Big Pharma, Biologics, Teva-Pharmaceuticals, Genentetech, Lobbyists, Health Care Reform, Special Interests, K Street, Health Care, Politics News
Hilary Kramer

You know a health care bill isn't right for the American people when it carves out a legal monopoly for Big Pharma and Botox. Our Congressional leaders should be capable of more.

Read Post

A Little-Discussed Issue That Puts "Care" Back in Health Care Reform

Kate Kelly | Posted 05.25.2011

Read More: Health Care Reform, Pharmaceutical Companies, FDA Approvals, Health Care, Cancer Treatments, Biologics, Chuck Schumer, Fda, Henry Waxman, Lupus, Food and Drug Administration, Chronic Fatigue Syndrome, Politics News
Kate Kelly

Legislation concerning the changes for the drug approval process on a special type of medicine (biologic medicines) could provide huge savings -- a major need with health care reform.

Read Post

Why We Can't Forget about HIV/AIDS in Health-Care Reform

David Mixner | Posted 11.17.2011

Read More: Health Care Reform, Senator Kennedy, HIV/AIDS, Biologics, Healthcare, Antiretroviral Drugs, Healthy Living News
David Mixner

For nearly three decades, too many people have died and millions more are living with HIV/AIDS' painful realities. Stated simply, it is far from over.

Read Post